|8.92||+0.0100||+0.11%||Vol 45.44K||1Y Perf -13.91%|
|Dec 7th, 2023 16:00 DELAYED|
|- -%||- -|
|Target Price||-||Analyst Rating||— — 0.00|
|Potential %||-||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★★★★ 66.95|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||★★★★★ 71.42|
|Price Range Ratio 52W %||40.48||Earnings Rating||—|
|Market Cap||152.47M||Earnings Date||-|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||53.39K|
|Avg. Monthly Volume||43.72K|
|Avg. Quarterly Volume||52.17K|
The Gabelli Healthcare & Wellness Trust of Beneficial Interest (NYSE: GRX) stock closed at 8.92 per share at the end of the most recent trading day (a 0.11% change compared to the prior day closing price) with a volume of 45.44K shares and market capitalization of 152.46M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Asset Management industry, Financial Services sector and employs 0 people. The Gabelli Healthcare & Wellness Trust of Beneficial Interest CEO is .
The one-year performance of The Gabelli Healthcare & Wellness Trust of Beneficial Interest stock is -13.91%, while year-to-date (YTD) performance is -13.23%. GRX stock has a five-year performance of -12.55%. Its 52-week range is between 7.73 and 10.67, which gives GRX stock a 52-week price range ratio of 40.48%
The Gabelli Healthcare & Wellness Trust of Beneficial Interest currently has a PE ratio of 16.70, a price-to-book (PB) ratio of 2.72, a price-to-sale (PS) ratio of -3.91, a price to cashflow ratio of 12.10, a PEG ratio of -, a ROA of 6.15%, a ROC of -% and a ROE of 22.02%. The company’s profit margin is 90.19%, its EBITDA margin is -%, and its revenue ttm is $-44 708 200.00 , which makes it $-2.62 revenue per share.
Of the last four earnings reports from The Gabelli Healthcare & Wellness Trust of Beneficial Interest, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. The Gabelli Healthcare & Wellness Trust of Beneficial Interest’s next earnings report date is -.
The consensus rating of Wall Street analysts for The Gabelli Healthcare & Wellness Trust of Beneficial Interest is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for The Gabelli Healthcare & Wellness Trust of Beneficial Interest stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
The Gabelli Healthcare & Wellness Trust of Beneficial Interest has a dividend yield of 5.87% with a dividend per share of $0.60 and a payout ratio of 42.00%.
The Gabelli Healthcare & Wellness Trust of Beneficial Interest has a Neutral technical analysis rating based on Technical Indicators (ADX : 6.40, ATR14 : 0.13, CCI20 : 98.38, Chaikin Money Flow : 0.00, MACD : 0.15, Money Flow Index : 80.43, ROC : 4.27, RSI : 66.61, STOCH (14,3) : 85.89, STOCH RSI : 0.79, UO : 58.90, Williams %R : -14.11), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of The Gabelli Healthcare & Wellness Trust of Beneficial Interest in the last 12-months were: Jeffrey Jonas (Buy at a value of $250 000)
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.